Japan Lifeline Co., Ltd. Stock price

Equities

7575

JP3754500001

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange 02:00:00 2024-03-28 am EDT 5-day change 1st Jan Change
1,205 JPY -0.66% Intraday chart for Japan Lifeline Co., Ltd. -4.67% -4.59%
Sales 2024 * 51.1B 338M Sales 2025 * 52.64B 348M Capitalization 90.29B 597M
Net income 2024 * 8.07B 53.35M Net income 2025 * 8B 52.85M EV / Sales 2024 * 1.48 x
Net cash position 2024 * 14.56B 96.25M Net cash position 2025 * 18.24B 121M EV / Sales 2025 * 1.37 x
P/E ratio 2024 *
11.9 x
P/E ratio 2025 *
11.9 x
Employees 1,166
Yield 2024 *
3.13%
Yield 2025 *
3.21%
Free-Float 59.18%
More Fundamentals * Assessed data
Dynamic Chart
Japan Lifeline Completes Cancellation of 7.16 Million Shares MT
Tranche Update on Japan Lifeline Co., Ltd.'s Equity Buyback Plan announced on May 10, 2023. CI
Japan Lifeline Co., Ltd.'s Equity Buyback announced on May 10, 2023, has closed with 3,000,000 shares, representing 3.9% for ¥3,319.77 million. CI
Japan Lifeline Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2024 CI
Japan Lifeline Co., Ltd. Announces the Appointment of Nobuo Takahashi as Operating Officer, Associate Executive Manager of CVG Business Unit CI
Japanese Shares Return to Green on Upbeat Economic Data MT
Japan Lifeline Buys Back Shares Worth Over 217 Million Yen MT
Tranche Update on Japan Lifeline Co., Ltd.'s Equity Buyback Plan announced on May 10, 2023. CI
Japan Lifeline Buys Back 244,300 Shares for 272.88 Million Yen MT
Japan Lifeline Co., Ltd. Announces Management Changes CI
Japan Lifeline Raises Forecasts for Fiscal 2024 After Better than Expected First Half MT
Japan Lifeline Co., Ltd. Revises Year End Dividend Guidance for the Fiscal Year 2024 CI
Japan Lifeline Co., Ltd. Revises Consolidated and Non-Consolidated Earnings Guidance for the Fiscal Year Ending 31, 2024 CI
Japan Lifeline Co., Ltd. Enters into Exclusive Distribution Agreement with Meril Life Sciences Pvt. Ltd CI
Tranche Update on Japan Lifeline Co., Ltd.'s Equity Buyback Plan announced on May 10, 2023. CI
More news
1 day-0.66%
1 week-4.82%
Current month-7.87%
1 month-5.34%
3 months-2.11%
6 months+3.97%
Current year-4.59%
More quotes
1 week
1 201.00
Extreme 1201
1 288.00
1 month
1 201.00
Extreme 1201
1 317.00
Current year
1 201.00
Extreme 1201
1 357.00
1 year
887.00
Extreme 887
1 357.00
3 years
880.00
Extreme 880
1 608.00
5 years
880.00
Extreme 880
2 065.00
10 years
76.88
Extreme 76.875
3 780.00
More quotes
Managers TitleAgeSince
Founder 70 81-02-05
Director of Finance/CFO - -
Chief Administrative Officer 52 98-04-30
Members of the board TitleAgeSince
Founder 70 81-02-05
Chief Operating Officer 65 84-08-31
Chief Administrative Officer 52 98-04-30
More insiders
Date Price Change Volume
24-03-28 1,205 -0.66% 266 500
24-03-27 1,255 +0.24% 236,400
24-03-26 1,252 -1.34% 199,000
24-03-25 1,269 -0.63% 146,800
24-03-22 1,277 +0.87% 138,300

Delayed Quote Japan Exchange, March 28, 2024 at 02:00 am EDT

More quotes
Japan Lifeline Co., Ltd. is a Japan-based company mainly engaged in the import, manufacture and sale of cardiac circulators and other medical devices. The Company is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
1,255 JPY
Average target price
1,450 JPY
Spread / Average Target
+15.54%
Consensus
  1. Stock
  2. Equities
  3. Stock Japan Lifeline Co., Ltd. - Japan Exchange